Advertisement
ASTH vs HCA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a StrongBuy and HCA is a StrongBuy.
Momentum Indicator for ASTH turns positive, indicating new upward trend
ASTH saw its Momentum Indicator move above the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 73 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ASTH's RSI Indicator exited the oversold zone, 23 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for ASTH just turned positive on October 02, 2026. Looking at past instances where ASTH's MACD turned positive, the stock continued to rise in 34 of 41 cases over the following month. The odds of a continued upward trend are 83%.
ASTH moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ASTH crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.
Following a +4.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASTH advanced for three days, in 241 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 58 cases where ASTH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
ASTH broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ASTH entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. ASTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.099) is normal, around the industry mean (204.137). P/E Ratio (42.878) is within average values for comparable stocks, (19.387). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.095) among similar stocks. P/S Ratio (0.485) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASTH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Momentum Indicator for HCA turns positive, indicating new upward trend
HCA saw its Momentum Indicator move above the 0 level on October 07, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In 64 of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for HCA just turned positive on October 08, 2026. Looking at past instances where HCA's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.
Following a +2.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCA advanced for three days, in 247 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Aroon Indicator entered an Uptrend today. In 206 of 322 cases where HCA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Bearish Trend Analysis
The 10-day RSI Indicator for HCA moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 49 similar instances where the indicator moved out of overbought territory. In 32 of the 49 cases, the stock moved lower in the following days. This puts the odds of a move lower at 65%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 34 of 66 cases where HCA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 52%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
HCA broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. HCA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 41 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-14.975) is normal, around the industry mean (204.137). P/E Ratio (15.202) is within average values for comparable stocks, (19.387). Projected Growth (PEG Ratio) (1.323) is also within normal values, averaging (2.498). Dividend Yield (0.007) settles around the average of (0.095) among similar stocks. P/S Ratio (1.264) is also within normal values, averaging (2.688).
ASTH | HCA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 39 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 84 Overvalued | 67 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 41 | |
SMR RATING 1..100 | 83 | 45 | |
PRICE GROWTH RATING 1..100 | 43 | 41 | |
P/E GROWTH RATING 1..100 | 69 | 60 | |
SEASONALITY SCORE 1..100 | 46 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HCA's Valuation (67) in the Hospital Or Nursing Management industry is in the same range as ASTH (84) in the null industry. This means that HCA’s stock grew similarly to ASTH’s over the last 12 months.
HCA's Profit vs Risk Rating (41) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (100) in the null industry. This means that HCA’s stock grew somewhat faster than ASTH’s over the last 12 months.
HCA's SMR Rating (45) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (83) in the null industry. This means that HCA’s stock grew somewhat faster than ASTH’s over the last 12 months.
HCA's Price Growth Rating (41) in the Hospital Or Nursing Management industry is in the same range as ASTH (43) in the null industry. This means that HCA’s stock grew similarly to ASTH’s over the last 12 months.
HCA's P/E Growth Rating (60) in the Hospital Or Nursing Management industry is in the same range as ASTH (69) in the null industry. This means that HCA’s stock grew similarly to ASTH’s over the last 12 months.
| ASTH | HCA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 72% | 2 days ago 65% |
| Stochastic ODDS (%) | 2 days ago 84% | 2 days ago 52% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 73% |
| MACD ODDS (%) | 2 days ago 83% | 2 days ago 70% |
| TrendWeek ODDS (%) | 2 days ago 79% | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 68% |
| Advances ODDS (%) | 3 days ago 76% | 9 days ago 71% |
| Declines ODDS (%) | 9 days ago 77% | 4 days ago 63% |
| BollingerBands ODDS (%) | 2 days ago 84% | 2 days ago 49% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 64% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASTH’s FA Score shows that 0 FA rating(s) are green while HCA’s FA Score has 0 green FA rating(s).
- ASTH’s FA Score: 0 green, 5 red.
- HCA’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASTH’s TA Score shows that 6 TA indicator(s) are bullish while HCA’s TA Score has 4 bullish TA indicator(s).
- ASTH’s TA Score: 6 bullish, 4 bearish.
- HCA’s TA Score: 4 bullish, 4 bearish.
Price Growth
ASTH (@Hospital/Nursing Management) experienced а -0.98% price change this week, while HCA (@Hospital/Nursing Management) price change was -2.35% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.57%. For the same industry, the average monthly price growth was -3.59%, and the average quarterly price growth was +21.50%.
Reported Earning Dates
ASTH is expected to report earnings on Nov 05, 2026.
HCA is expected to report earnings on Oct 27, 2026.
Industries' Descriptions
@Hospital/Nursing Management (+0.57% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
HCA and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCA has been loosely correlated with UHS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if HCA jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To HCA | 1D Price Change % | ||
|---|---|---|---|---|
| HCA | 100% | -1.36% | ||
| UHS - HCA | 66% Loosely correlated | -1.48% | ||
| THC - HCA | 62% Loosely correlated | -1.17% | ||
| ENSG - HCA | 39% Loosely correlated | -1.51% | ||
| SGRY - HCA | 32% Poorly correlated | -0.58% | ||
| CON - HCA | 32% Poorly correlated | +0.85% | ||
More | ||||